Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT06213129 |
Other study ID # |
Na and UF profiling on ESRD |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
January 15, 2024 |
Est. completion date |
August 28, 2024 |
Study information
Verified date |
January 2024 |
Source |
Assiut University |
Contact |
Neveen Hassan |
Phone |
01069309948 |
Email |
nivoh86[@]gmail.com |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
The aim of this study is to evaluate the effects of sodium and UF profiling on hemodynamic
stability, interdialytic weight gain, and intradialytic complications
Description:
Sodium and ultrafiltration profiling are method of dialysis in which dialysate sodium
concentration and ultrafiltration rate are altered during the course of the dialysis session.
Several sodium profiling methods are available. Increasing, decreasing, or alternating sodium
concentrations may be used, although decreasing profiling has been the most accepted. The
decrease in dialysate sodium concentration may be linear, stepwise, or exponential As
different sodium profiling methods may have distinct impacts, different dialysis modalities
may also affect the outcome of profiling. Although not as commonly used, hemodiafiltration
HDF which utilizes convective clearance in addition to diffusion, may change the results of
sodium profiling Such intervention alleviates the acute decline in intravascular volume
during ultrafiltration UF as well as the decline in intradialytic plasma osmolarity and the
consequent disequilibrium syndrome Sodium profiling enhances the internal plasma refill rate
and helps to stabilize the blood pressure, thus decreasing the risk of Intra dialytic
hypotension. It is imperative to limit or prevent intradialytic hypotension since it does not
only affect the patient's comfort but also increases the risk of vascular access thrombosis,
myocardial fibrosis and stunning, cardiovascular events, and mortality So it has potential
benefits in terms of intradialytic morbidity and mortality as well as quality of life and
long-term cardiovascular events; nevertheless, it may also predispose to interdialytic
hypernatremia and increased interdialytic hypernatremia and interdialytic weight gain IDWG
and hypertension. Fatigue and thirst have been reported with sodium profiling and the
resulting sodium overload.
Another method to avoid intradialytic hemodynamic instability is UF profiling. In it, a
larger portion of total UF volume is extracted during the first part of a dialysis session,
after which the UF rate is decreased in order to maintain hemodynamic stability However,
achieving a correct intradialytic sodium balance is a much more difficult task in clinical
practice. With the advances in technology, automatic computer-based programs can be used
today to calculate intradialytic sodium removal. These models use real-time data from
patients and are being used to reach underdialysis sodium, weight in Kg, and blood volume
targets. Such biofeedback systems enable to achieve sodium balance neutral sodium profile and
UF profile automatically. Currently, there are various commercial dialysis systems that
calculate dialysate and UF profiles with algorithms based on the prescribed decrease in body
weight and sodium mass.
The aim of study to determine which specific profiling methods is more efficacious in
preventing specific symptoms and which profiling method has the most utility in routine
clinical practice. Furthermore, more qualitative data is warranted for subjective analysis of
quality of life and personal well-being.